Point: Efficacy of bronchial thermoplasty for patients with severe asthma. Is there sufficient evidence? Yes

Chest

Volumn 140, Issue 3, 2011, Pages 573-575

  Shifren, Adrian ^a   Chen, Alex ^a   Castro, Mario ^a   Michaud, Gaetane ^b   Ernst, Armin ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; OMALIZUMAB;

ADD ON THERAPY; ADVERSE OUTCOME; ALLERGIC ASTHMA; ASTHMA; BRONCHIAL THERMOPLASTY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; HYPERTHERMIC THERAPY; LOW DRUG DOSE; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOFREQUENCY; REVIEW;

EID: 80052681125     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1410     Document Type: Editorial

References (21)

1. L Antonicelli C Bucca M Neri Asthma severity and medical resource utilisation Eur Respir J 23 5 2004 723 729
2. PJ Brown HW Greville KE Finucane Asthma and irreversible airflow obstruction Thorax 39 2 1984 131 136
3. RC Strunk AL Sternberg SJ Szefler RS Zeiger B Bender J. Tonascia Childhood Asthma Management Program (CAMP) Research Group Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents J Pediatr 154 5 2009 682 687
4. CM Dolan KE Fraher ER Bleecker TENOR Study Group Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma Ann Allergy Asthma Immunol 92 1 2004 32 39
5. MG Cisternas PD Blanc IH Yen A comprehensive study of the direct and indirect costs of adult asthma J Allergy Clin Immunol 111 6 2003 1212 1218
6. WC Moore ER Bleecker D Curran-Everett National Heart, Lung, Blood Institute's Severe Asthma Research Program Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program J Allergy Clin Immunol 119 2 2007 405 413
7. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health 2007 National Heart, Lung, and Blood Institute
8. W Busse J Corren BQ Lanier Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma J Allergy Clin Immunol 108 2 2001 184 190
9. M Solèr J Matz R Townley The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics Eur Respir J 18 2 2001 254 261
10. ST Holgate AG Chuchalin J Hébert Omalizumab 011 International Study Group Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma Clin Exp Allergy 34 4 2004 632 638
11. GJ Rodrigo H Neffen JA Castro-Rodriguez Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review Chest 139 1 2011 28 35
12. PG Cox J Miller W Mitzner AR Leff Radiofrequency ablation of airway smooth muscle for sustained treatment of asthma: preliminary investigations Eur Respir J 24 4 2004 659 663
13. JD Miller G Cox L Vincic CM Lombard BE Loomas CJ Danek A prospective feasibility study of bronchial thermoplasty in the human airway Chest 127 6 2005 1999 2006
14. M Castro A Rubin M Laviolette Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled trial Am J Respir Crit Care Med 181 2 2010 116 124
15. G Cox NC Thomson AS Rubin AIR Trial Study Group Asthma control during the year after bronchial thermoplasty N Engl J Med 356 13 2007 1327 1337
16. ID Pavord G Cox NC Thomson RISA Trial Study Group Safety and efficacy of bronchial thermoplasty in symptomatic, severe asthma Am J Respir Crit Care Med 176 12 2007 1185 1191
17. M Castro A Rubin M Laviolette Two-year persistence of effect of bronchial thermoplasty (BT) in patients with severe asthma: AIR2 trial [abstract] Chest 138 suppl 4 2010 768A
18. M Castro AI Musani ML Mayse NS Shargill Bronchial thermoplasty: a novel technique in the treatment of severe asthma Ther Adv Respir Dis 4 2 2010 101 116
19. SS Gupta Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma Am J Respir Crit Care Med 182 12 2010 1565 1567
20. G Cox M Laviolette A Rubin Long term safety of bronchial thermoplasty (BT): 3 year data from multiple studies [abstract] Am J Respir Crit Care 179 Meeting abstracts 2009 A2780
21. LG Heaney E Conway C Kelly Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol Thorax 58 7 2003 561 566